# Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass

> **NCT07426237** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Hospital Nossa Senhora da Conceicao** · enrollment: 60 (estimated)

## Conditions studied

- Myocardial Protection

## Interventions

- **DRUG:** Adenoseine
- **DRUG:** Placebo (sterile distilled water)

## Key facts

- **NCT ID:** NCT07426237
- **Lead sponsor:** Hospital Nossa Senhora da Conceicao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-30
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07426237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07426237, "Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07426237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*